Tus-Pharmaceutical Group Co., Ltd. (SHE:000590)

Tus-Pharmaceutical Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 11, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	2,881	1,703	2,146	2,141	2,366	2,031
Market Cap Growth	103.04%	-20.65%	0.22%	-9.51%	16.51%	-29.10%
Enterprise Value	2,801	1,625	2,045	1,954	2,022	1,680
Last Close Price	12.03	7.11	8.96	8.94	9.88	8.48
PE Ratio	-	-	84.99	118.22	66.76	89.37
Forward PE	-	91.43	91.43	91.43	91.43	91.43
PS Ratio	8.50	4.96	5.30	6.11	7.87	7.38
PB Ratio	4.93	2.83	2.95	3.05	3.47	3.15
P/TBV Ratio	6.55	3.75	4.67	5.30	4.33	4.01
P/FCF Ratio	-	-	-	59.82	-	115.55
P/OCF Ratio	79.49	97.92	-	39.30	93.90	39.45
EV/Sales Ratio	8.26	4.74	5.05	5.57	6.72	6.11
EV/EBITDA Ratio	-	6378.70	51.76	58.25	47.48	50.62
EV/EBIT Ratio	-	-	143.00	161.08	78.18	88.35
EV/FCF Ratio	-176.24	-	-	54.59	-	95.60
Debt / Equity Ratio	0.23	0.16	0.13	0.19	0.01	0.01
Debt / EBITDA Ratio	20.89	31.32	2.25	3.67	0.19	0.15
Debt / FCF Ratio	-	-	-	3.74	-	0.28
Asset Turnover	0.32	0.32	0.35	0.33	0.32	0.32
Inventory Turnover	1.34	1.44	1.56	1.68	1.96	2.40
Quick Ratio	1.49	1.57	1.63	1.50	2.44	2.83
Current Ratio	2.12	2.12	2.17	1.95	2.96	3.16
Return on Equity (ROE)	-18.80%	-19.14%	3.48%	2.62%	5.34%	3.59%
Return on Assets (ROA)	-1.39%	-1.48%	0.77%	0.71%	1.74%	1.37%
Return on Capital (ROIC)	-1.96%	-2.11%	1.08%	0.99%	2.41%	1.87%
Return on Capital Employed (ROCE)	-	-	1.60%	1.40%	3.30%	2.60%
Earnings Yield	-4.14%	-7.37%	1.18%	0.85%	1.50%	1.12%
FCF Yield	-0.55%	-0.86%	-2.40%	1.67%	-0.03%	0.86%
Payout Ratio	-	-	16.62%	1.87%	0.18%	-
Buyback Yield / Dilution	-0.01%	-	-	-	-	0.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.